1. African Americans, Kidney Disease, and Drug Development: A Regulatory Perspective 
Carolina Panico, Aliza Thompson 
American Journal of Kidney Diseases 
Volume 72, Issue 5, Pages S33-S36 (November 2018)
DOI: /j.ajkd
Copyright © Terms and Conditions

2. Figure 1
Demographics of efficacy trials by race for Veltassa (patiromer).
Data source: US Food and Drug Administration.15
American Journal of Kidney Diseases  , S33-S36DOI: ( /j.ajkd )
Copyright © Terms and Conditions

3. Figure 2
Demographics of efficacy trials by race for Entresto (sacubitril/valsartan). Data source: US Food and Drug Administration.15 ∗All other races combined.
American Journal of Kidney Diseases  , S33-S36DOI: ( /j.ajkd )
Copyright © Terms and Conditions